secwatch.observer — SEC 8-K summary
======================================

Issuer:     MiNK Therapeutics, Inc. (INKT)
CIK:        0001840229
Form:       8-K
Filed at:   2022-01-06T23:59:59+00:00
Accession:  0001193125-22-003536
Event type: leadership
Sentiment:  neutral
Materiality: 0.20
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

MiNK Therapeutics board member Dr. Walter Flamenbaum retires as planned
-----------------------------------------------------------------------

- Dr. Walter Flamenbaum retired from the Board of Directors effective December 31, 2021.
- His retirement was previously disclosed in the Company's Amended Registration Statement filed on October 12, 2021.
- No immediate replacement was announced; the departure was part of a previously planned transition.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1840229/000119312522003536/0001193125-22-003536-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1840229/000119312522003536/d268923d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-003536

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer